Search for: "Mobil Oil Corp. v. Attorney General"
Results 41 - 60
of 69
Sorted by Relevance
|
Sort by Date
2 Feb 2022, 4:05 am
Mobil Oil Corp., 301 Ill. [read post]
28 Aug 2019, 8:05 am
As Havens Realty Corp. [read post]
12 Aug 2013, 11:34 am
Plus, the opinion is written by a recent Attorney General of the United States, which should give it extra prominence. [read post]
7 Jun 2010, 9:54 am
Click Here US District Court Decision in US v. [read post]
7 Jun 2010, 10:04 am
Click Here US District Court Decision in US v. [read post]
19 Sep 2008, 6:00 pm
: (Ars Technica), Google, GE join forces for green tech research, lobbying: (Ars Technica), AIPPI Congress: how to protect you IP rights in virtual worlds (Managing Intellectual Property), Industry still wary of ICANN plan for new top-level internet domains: (Intellectual Property Watch), Ubuntu-Firefox EULA dustup reignites OSS licensing debate: (Ars Technica), Media standard backers attempt Apple-less solo run: (Out-Law), Open Source in Mobile conference: OpenMoko CEO says embrace… [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation… [read post]
29 Feb 2008, 8:00 am
, (EDTexweblog.com), (Patent Prospector), (Peter Zura's 271 Patent Blog), (IPBiz), (Against Monopoly), (Philip Brooks), (IPBiz), Indian government to consider whether to grant compulsory licenses to Natco for the exportation of generic versions of Tarceva and Sutent (Sunitinib) to Nepal : (Spicy IP), (Spicy IP), (Spicy IP), (Generic Pharmaceuticals & IP), (IP Law360), (Spicy IP),GlobalGlobal - GeneralIntellectual privilege or imaginary property? [read post]
9 Jan 2017, 10:12 pm
See Flag-Redfern Oil Co. v. [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA … [read post]
23 Mar 2012, 12:42 pm
Power Co. v. [read post]
December 29, 2009 – Environmental Law Settlements, Decisions, Regulatory Actions and Lawsuit Filings
29 Dec 2009, 5:50 pm
—Ted Potts, The Tribune Democrat, December 23, 2009 The attorney for PennEnvironment said Wednesday he is unsure what – if anything – the environmental group will do now that a lawsuit it filed in 2007 concerning pollution of the Conemaugh River has been dismissed. [read post]
December 29, 2009 – Environmental Law Settlements, Decisions, Regulatory Actions and Lawsuit Filings
29 Dec 2009, 5:46 pm
—Ted Potts, The Tribune Democrat, December 23, 2009 The attorney for PennEnvironment said Wednesday he is unsure what – if anything – the environmental group will do now that a lawsuit it filed in 2007 concerning pollution of the Conemaugh River has been dismissed. [read post]
9 Jun 2018, 11:15 am
Milward v. [read post]
28 Jun 2013, 6:01 pm
” (Atari Games Corp. v. [read post]
13 Sep 2010, 8:43 am
But his administration’s decision on this case, Connecticut v. [read post]
1 Feb 2019, 10:51 am
Resolving the partner-guardian tension: the key to general counsel independence. [read post]
4 Nov 2014, 2:34 pm
Generally speaking (though with some potential exceptions), the answer is Oklahoma law, as the California Supreme Court held in McCann v. [read post]
2 Jan 2019, 2:55 pm
Capital Corp., 439 S.W.3d 571, 575 (Tex. [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files… [read post]
